Literature DB >> 33734027

Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity.

Satoko Yamaoka1, Hideki Ebihara1.   

Abstract

Ebola virus (EBOV), belonging to the species Zaire ebolavirus in the genus Ebolavirus, causes a severe febrile illness in humans with case fatality rates (CFRs) up to 90%. While there have been six virus species classified, which each have a single type virus in the genus Ebolavirus, CFRs of ebolavirus infections vary among viruses belonging to each distinct species. In this review, we aim to define the ebolavirus species-specific virulence on the basis of currently available laboratory and experimental findings. In addition, this review will also cover the variant-specific virulence of EBOV by referring to the unique biological and pathogenic characteristics of EBOV variant Makona, a new EBOV variant isolated from the 2013-2016 EBOV disease outbreak in West Africa. A better definition of species-specific and variant-specific virulence of ebolaviruses will facilitate our comprehensive knowledge on genus Ebolavirus biology, leading to the development of therapeutics against well-focused pathogenic mechanisms of each Ebola disease.

Entities:  

Keywords:  Bundibugyo virus; Ebola virus; Reston virus; Sudan virus; Taï Forest virus; case fatality rates; virulence

Year:  2021        PMID: 33734027      PMCID: PMC7993122          DOI: 10.1080/21505594.2021.1898169

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  192 in total

1.  Robust and sustained immune activation in human Ebola virus infection.

Authors:  Judith N Mandl; Mark B Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-07       Impact factor: 11.205

2.  Ebolavirus VP35 coats the backbone of double-stranded RNA for interferon antagonism.

Authors:  Shridhar Bale; Jean-Philippe Julien; Zachary A Bornholdt; Alexander S Krois; Ian A Wilson; Erica Ollmann Saphire
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

3.  Immune parameters and outcomes during Ebola virus disease.

Authors:  Stéphanie Reynard; Alexandra Journeaux; Emilie Gloaguen; Justine Schaeffer; Hugo Varet; Natalia Pietrosemoli; Mathieu Mateo; Nicolas Baillet; Cédric Laouenan; Hervé Raoul; Jimmy Mullaert; Sylvain Baize
Journal:  JCI Insight       Date:  2019-01-10

4.  Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.

Authors:  St Patrick Reid; Charalampos Valmas; Osvaldo Martinez; Freddy Mauricio Sanchez; Christopher F Basler
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

5.  An analysis of features of pathogenesis in two animal models of Ebola virus infection.

Authors:  E I Ryabchikova; L V Kolesnikova; S V Luchko
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

6.  Modeling the Disease Course of Zaire ebolavirus Infection in the Outbred Guinea Pig.

Authors:  Robert W Cross; Karla A Fenton; Joan B Geisbert; Chad E Mire; Thomas W Geisbert
Journal:  J Infect Dis       Date:  2015-06-02       Impact factor: 5.226

7.  Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus.

Authors:  Darryl Falzarano; Friederike Feldmann; Allen Grolla; Anders Leung; Hideki Ebihara; James E Strong; Andrea Marzi; Ayato Takada; Shane Jones; Jason Gren; Joan Geisbert; Steven M Jones; Thomas W Geisbert; Heinz Feldmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

8.  Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses.

Authors:  Siddhartha Mahanty; Karen Hutchinson; Sudhanshu Agarwal; Michael McRae; Pierre E Rollin; Bali Pulendran
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

9.  The role of the Type I interferon response in the resistance of mice to filovirus infection.

Authors:  Mike Bray
Journal:  J Gen Virol       Date:  2001-06       Impact factor: 3.891

10.  Multi-platform 'Omics Analysis of Human Ebola Virus Disease Pathogenesis.

Authors:  Amie J Eisfeld; Peter J Halfmann; Jason P Wendler; Jennifer E Kyle; Kristin E Burnum-Johnson; Zuleyma Peralta; Tadashi Maemura; Kevin B Walters; Tokiko Watanabe; Satoshi Fukuyama; Makoto Yamashita; Jon M Jacobs; Young-Mo Kim; Cameron P Casey; Kelly G Stratton; Bobbie-Jo M Webb-Robertson; Marina A Gritsenko; Matthew E Monroe; Karl K Weitz; Anil K Shukla; Mingyuan Tian; Gabriele Neumann; Jennifer L Reed; Harm van Bakel; Thomas O Metz; Richard D Smith; Katrina M Waters; Alhaji N'jai; Foday Sahr; Yoshihiro Kawaoka
Journal:  Cell Host Microbe       Date:  2017-11-16       Impact factor: 21.023

View more
  4 in total

1.  Assessment of Life Cycle Modeling Systems as Prediction Tools for a Possible Attenuation of Recombinant Ebola Viruses.

Authors:  Bianca S Bodmer; Thomas Hoenen
Journal:  Viruses       Date:  2022-05-13       Impact factor: 5.818

Review 2.  Recent Trends in Protective Textiles against Biological Threats: A Focus on Biological Warfare Agents.

Authors:  Joana C Antunes; Inês P Moreira; Fernanda Gomes; Fernando Cunha; Mariana Henriques; Raúl Fangueiro
Journal:  Polymers (Basel)       Date:  2022-04-14       Impact factor: 4.967

3.  Comparison of Aerosol Stability of Different Variants of Ebola Virus and Marburg Virus and Virulence of Aerosolised Ebola Virus in an Immune-Deficient Mouse.

Authors:  Sophie J Smither; Lin S Eastaugh; Mark S Lever
Journal:  Viruses       Date:  2022-04-09       Impact factor: 5.818

Review 4.  The Key Role of Lysosomal Protease Cathepsins in Viral Infections.

Authors:  Melania Scarcella; Danila d'Angelo; Mariangela Ciampa; Simona Tafuri; Luigi Avallone; Luigi Michele Pavone; Valeria De Pasquale
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.